Literature DB >> 14981547

ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest.

Daniel E Todd1, Ruth M Densham, Sarah A Molton, Kathryn Balmanno, Catherine Newson, Claire R Weston, Andrew P Garner, Linda Scott, Simon J Cook.   

Abstract

To study the mechanisms by which mitogen- and stress-activated protein kinases regulate cell cycle re-entry, we have used a panel of conditional kinases that stimulate defined MAPK or SAPK cascades. Activation of DeltaMEKK3:ER* during serum restimulation of quiescent cells causes a strong activation of JNK1 and p38alpha but only a modest potentiation of serum-stimulated ERK1/2 activity. In CCl39 cells this promoted a sustained G1 arrest that correlated with decreased expression of cyclin D1 and Cdc25A, increased expression of p21CIP1 and inhibition of CDK2 activity. In Rat-1 cells, in which p21(CIP1) expression is silenced by methylation, DeltaMEKK3:ER* activation caused only a transient delay in the S phase entry rather than a sustained G1 arrest. Furthermore, p21CIP1-/- 3T3 cells were defective for the DeltaMEKK3:ER*-induced G1 cell cycle arrest compared to their wild-type counterparts. These results suggest that activated DeltaMEKK3:ER* inhibits the G1 --> S progression by two kinetically distinct mechanisms, with expression of p21CIP1 being required to ensure a sustained G1 cell cycle arrest. The ERK1/2 and p38alphabeta pathways cooperated to induce p21CIP1 expression and inhibition of p38alphabeta caused a partial reversal of the cell cycle arrest. In contrast, selective activation of ERK1/2 by DeltaRaf-1:ER* did not inhibit serum stimulated cell cycle re-entry. Finally, selective activation of JNK by DeltaMEKK1:ER* failed to inhibit cell cycle re-entry, even in cells that retained wild-type p53, arguing against a major role for JNK alone in antagonizing the G1 --> S transition. Copyright 2004 Nature Publishing Group

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14981547     DOI: 10.1038/sj.onc.1207467

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

1.  Human regulatory T cells induce T-lymphocyte senescence.

Authors:  Jian Ye; Xingxu Huang; Eddy C Hsueh; Qunyuan Zhang; Chunling Ma; Yanping Zhang; Mark A Varvares; Daniel F Hoft; Guangyong Peng
Journal:  Blood       Date:  2012-06-21       Impact factor: 22.113

2.  KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.

Authors:  Mark Cannon; Ethel Cesarman; Chris Boshoff
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  Phosphorylation of Hsl1 by Hog1 leads to a G2 arrest essential for cell survival at high osmolarity.

Authors:  Josep Clotet; Xavier Escoté; Miquel Angel Adrover; Gilad Yaakov; Eloi Garí; Martí Aldea; Eulàlia de Nadal; Francesc Posas
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

4.  Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model.

Authors:  Peng Ru; Robert Steele; Pratibha V Nerurkar; Nancy Phillips; Ratna B Ray
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-12

5.  Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo.

Authors:  Qian-mei Zhou; Xiu-feng Wang; Xin-jun Liu; Hui Zhang; Yi-yu Lu; Shi-bing Su
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

6.  Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway.

Authors:  Wayne Chris Hawkes; Zeynep Alkan
Journal:  J Biol Chem       Date:  2012-06-22       Impact factor: 5.157

7.  Anticolorectal cancer effects and pharmacokinetic application of 2, 2-Bis [4-(4-amino-3-hydroxyphenoxy) phenyl] adamantane.

Authors:  Po-Sheng Yang; Jane-Jen Wang; Tung-Hu Tsai; Yea-Hwey Wang; Woan-Ching Jan; Shih-Ping Cheng; Chin-Wen Chi; Yi-Chiung Hsu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

8.  Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer.

Authors:  Yun Feng; Yanru Wang; Hongliang Liu; Zhensheng Liu; Coleman Mills; Kouros Owzar; Jichun Xie; Younghun Han; David C Qian; Rayjean J Hung Rj; Yonathan Brhane; John McLaughlin; Paul Brennan; Heike Bickeböller; Albert Rosenberger; Richard S Houlston; Neil Caporaso; Maria Teresa Landi; Irene Brüske; Angela Risch; Yuanqing Ye; Xifeng Wu; David C Christiani; Christopher I Amos; Qingyi Wei
Journal:  Mol Carcinog       Date:  2017-10-31       Impact factor: 4.784

9.  Regulatory role of rpL3 in cell response to nucleolar stress induced by Act D in tumor cells lacking functional p53.

Authors:  Annapina Russo; Valentina Pagliara; Francesco Albano; Davide Esposito; Vinay Sagar; Fabrizio Loreni; Carlo Irace; Rita Santamaria; Giulia Russo
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

10.  A role for p38 stress-activated protein kinase in regulation of cell growth via TORC1.

Authors:  Megan Cully; Alice Genevet; Patricia Warne; Caroline Treins; Tao Liu; Julie Bastien; Buzz Baum; Nic Tapon; Sally J Leevers; Julian Downward
Journal:  Mol Cell Biol       Date:  2009-11-16       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.